Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Tablets 30 X 150 mg |
|
80700 | 2488 |
Related information
Dosage
One tablet per day.
See prescribing information for full details.
Indications
In patients with locally advanced prostate cancer (T3-T4, any N, M0; T1-T2, N+, M0), as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy.For the management of patients with locally advanced, non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.
Contra-Indications
Females and children. Must not be given to any patient who has shown a hypersensitivity to the active substance or any of the excipients. Co-administration of terfenadine, astemizole or cisapride is contraindicated.
Special Precautions
Please contact distributor for full information.
Side Effects
Please contact distributor for full information.
Drug interactions
Please contact distributor for full information.
